20946. COMBINACIÓN DE LA PROTEÍNA ÁCIDA FIBRILAR GLIAL Y LA CADENA LIGERA DE LOS NEUROFILAMENTOS EN SUERO PARA PREDECIR EL EMPEORAMIENTO DE LA DISCAPACIDAD Y LA RESPUESTA TERAPÉUTICA EN ESCLEROSIS MÚLTIPLE

Autor: E. Monreal Laguillo, J. Fernández Velasco, R. Álvarez Lafuente, S. Sainz de la Maza Cantero, M. García Sánchez, S. Llufriu, B. Casanova, M. Comabella, S. Martínez Yélamos, D. Galimberti, L. Ramió Torrentà, M. Martínez Ginés, Y. Aladro, L. Ayuso, J. Martínez Rodríguez, L. Brieva, N. Villarrubia, S. Eichau, A. Rodero Romero, M. Espiño, Y. Blanco, A. Saiz, X. Montalban, M. Tintoré, M. Domínguez Mozo, J. Cuello, L. Romero Pinel, L. Ghezzi, B. Pilo de la Fuente, F. Pérez Miralles, A. Quiroga Varela, L. Rubio, F. Rodríguez Jorge, J. Chico García, R. Sainz Amo, J. Masjuan Vallejo, L. Costa-Frossard França, L. Villar

Publikováno v: Neurology Perspectives, Vol 4, Iss , Pp 60- (2024)

Externí odkaz: https://doaj.org/article/c731e7c223794885a213525f8354681e

COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis

Autor: Susana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Raquel Sainz-Amo, Lucienne Costa-Frossard, Jaime Masjuan, Luisa María Villar

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

ObjectiveTo evaluate the safety of COVID-19 vaccines in patients with multiple sclerosis (MS) by assessing their impact on serum neurofilament light chain (sNfL) levels as a marker of neuroaxonal damage.MethodsSingle-center observational longitudinal

Externí odkaz: https://doaj.org/article/042d07f429b0483597015d2e09baa5d8

Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults.

Autor: Rodero-Romero, Alexander¹ (AUTHOR) alexander.rodero@salud.madrid.org, Monreal, Enric² (AUTHOR) penry02@hotmail.com, Sainz-Amo, Raquel² (AUTHOR) raquelsainzamo@gmail.com, García Domínguez, José Manuel³ (AUTHOR) jgarciadominguez@salud.madrid.org, Villarrubia, Noelia¹ (AUTHOR) noelia.villarrubia@salud.madrid.org, Veiga-González, Jose Luís¹ (AUTHOR) joseluis.veiga@salud.madrid.org, Fernández-Velasco, José Ignacio¹ (AUTHOR) jfvelasco@salud.madrid.org, Goicochea-Briceño, Haydee³ (AUTHOR), Rodríguez-Jorge, Fernando² (AUTHOR) deterodriguez@hotmail.com, Sainz de la Maza, Susana² (AUTHOR) susana.sainzdelamaza@salud.madrid.org, Chico-García, Juan Luís² (AUTHOR) juanluis.chico.garcia@gmail.com, Muriel, Alfonso⁴ (AUTHOR) alfonso.muriel@uah.es, Masjuan, Jaime² (AUTHOR) jaime.masjuan@salud.madrid.org, Costa-Frossard, Lucienne² (AUTHOR) lucienne.costa@salud.madrid.org, Villar, Luisa María¹ (AUTHOR) luisamaria.villar@salud.madrid.org

Publikováno v: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 14, p7808. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine

Autor: Alexander Rodero-Romero, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, Enric Monreal, Paulette Esperanza Walo-Delgado, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, Rafael Rodríguez-Ramos, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar

Publikováno v: Vaccines, Vol 11, Iss 9, p 1399 (2023)

This single-center study included 68 multiple sclerosis (MS) patients who received the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination from one of several approved vaccine preparations in Spain. Blood samples were collected o

Externí odkaz: https://doaj.org/article/4d8709038bee489ea32a0e871e762155